ELV

SELL

Elevance Health, Inc.

Healthcare · Rank #414 · Analyzed Oct 18, 2026

$428.26

Current Price

$391.52

Intrinsic Value

-8.6%

Upside/Downside

1.5/10

Score

1.5/5

Quality

Analysis Summary

Valuation Consensus0/2 methods agree

Quality Score1.5/5.0

Framework RatingSELL

Price vs Intrinsic ValueOvervalued by 8.6%

Fair Value Range

Low$309.34

Base (IV)$391.52

High$472.80

Entry Points

Conservative$216.54

Moderate$309.34

Aggressive$274.06

Quality & Moat Breakdown

Return on Equity11.1% → 0.5/1.0

Debt LevelD/E 69 → 0/1.0

Revenue QualityGrowth 12.6%, margin Δ+0.0% +recovery → 1.0/1.0

Moat Strength0.5/5 → 0/1.0

Profit Margins2.5% → 0/1.0

Methodology

This analysis uses a unified valuation framework combining three methods, Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation, with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.